반응식
[NH2:1][CH2:2][CH:3]([C:9]1([CH3:14])[O:13][CH2:12][CH2:11][O:10]1)[C:4]([O:6][CH2:7][CH3:8])=[O:5].[N+:15]([C:18]1[CH:28]=[CH:27][CH:26]=[C:20]2[C:21]([O:23][C:24](=O)[C:19]=12)=[O:22])([O-:17])=[O:16]>>[N+:15]([C:18]1[CH:28]=[CH:27][CH:26]=[C:20]2[C:19]=1[C:24](=[O:23])[N:1]([CH2:2][CH:3]([C:9]1([CH3:14])[O:10][CH2:11][CH2:12][O:13]1)[C:4]([O:6][CH2:7][CH3:8])=[O:5])[C:21]2=[O:22])([O-:17])=[O:16]참가 물질
3
실험 절차
Ethyl 3-(4-nitro-1,3-dioxo-1,3-dihydro-isoindol-2-yl)-2-(2-methyl-[1,3]dioxolan-2-yl)propionate was prepared (0.64 g, 51%) in the same manner as described in the above example 5 (20) from ethyl 3-amino-2-(2-methyl-[1,3]dioxolan-2-yl)propionate (0.68 g, 3.34 mmol) and 3-nitrophthalic anhydride (0.84 g, 4.33 mmol), and the obtained product was identified with the following NMR data.
출처 및 근거
- ORD 기록
- ord-a8f84cf070604788a184785d3e608165
- 출처 데이터셋
- uspto-grants-2006_08
- 특허 번호
- US07094908B2
연결된 노트
불러오는 중…